Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1994 Nov-Dec;22(6):430-6.
doi: 10.1007/BF01715507.

Teicoplanin: 10 years of clinical experience

M Trautmann  1 , H Wiedeck, M Ruhnke, M Oethinger, R Marre
Affiliations
Review

Teicoplanin: 10 years of clinical experience

M Trautmann et al. Infection. 1994 Nov-Dec.

Abstract

The teichomycin antibiotics have been discovered and chemically purified in the late 1970s. Teicoplanin, one of the major derivatives of this group, has been introduced into clinical use in 1984. In Germany, teicoplanin was licensed in 1988 and now ranks among the antimicrobial agents most frequently used in intensive care units. Due to its reduced rate of side effects compared to vancomycin, its longer serum half-life and a simplified mode of application, teicoplanin has become the glycopeptide of choice in many hospitals. The present review summarizes in vitro activity data, pharmacokinetics, and clinical experience with teicoplanin, with special consideration of currently recommended doses and serum levels.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Scand J Infect Dis Suppl. 1990;72:54-60 - PubMed
    1. J Antimicrob Chemother. 1993 Dec;32(6):792-6 - PubMed
    1. Antimicrob Agents Chemother. 1990 May;34(5):899-900 - PubMed
    1. Antimicrob Agents Chemother. 1992 Jan;36(1):115-20 - PubMed
    1. J Antimicrob Chemother. 1993 Mar;31(3):438-9 - PubMed

MeSH terms